MedTrace Logo

Methadone Expansion in Detention Though the Hospital/Clinic Designation

NCT07707934 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-16

No results posted yet for this study

Summary

The goal of this clinical trial is to improve implementation of hospital/clinic methadone in several carceral systems and study the effects of implementation on patient outcomes.

This study has four Aims:

* Evaluate an intervention for carceral staff that will receive individual coaching and group didactic sessions focused on improving adoption and implementation of hospital/clinic methadone. Effects of this intervention will be measured via qualitative interviews and baseline, midpoint and final surveys of participants.
* Apply a trial emulation approach to electronic health records from three prison systems currently using hospital/clinic methadone to evaluate the effect of implementation on the initiation and retention of medications for opioid use disorder treatment.
* Link Medicaid data to electronic health records from one prison system implementing hospital/clinic methadone to examine the effect of implementation on post-release outcomes, including MOUD use and broader healthcare utilization.
* Examine the cost effectiveness and budgetary impact of implementing hospital/clinic methadone.

Conditions

Interventions

OTHER

Learning Collaborative

All participants will receive individual and group coaching sessions to facilitate implementation of the hospital/clinic designation.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • Brown University

    collaborator OTHER

  • Brendan Saloner

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-09-30
Completion
2030-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07707934 on ClinicalTrials.gov